Your browser doesn't support javascript.
loading
Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2 Mutation Positive Non-Small Cell Lung Cancer.
Azar, Ibrahim; Alkassis, Samer; Fukui, Jami; Alsawah, Fares; Fedak, Kalub; Al Hallak, Mohammed Najeeb; Sukari, Ammar; Nagasaka, Misako.
Afiliación
  • Azar I; Department of Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI, USA.
  • Alkassis S; Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI, USA.
  • Fukui J; University of Hawaii Manoa Cancer Center, John A. Burns School of Medicine, Honolulu, HI, USA.
  • Alsawah F; Department of Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI, USA.
  • Fedak K; Department of Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI, USA.
  • Al Hallak MN; Department of Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI, USA.
  • Sukari A; Department of Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI, USA.
  • Nagasaka M; Department of Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI, USA.
Lung Cancer (Auckl) ; 12: 103-114, 2021.
Article en En | MEDLINE | ID: mdl-34675733

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Lung Cancer (Auckl) Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Lung Cancer (Auckl) Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda